Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

The Lancet
Aug 15, 2020 Volume 396 Number 10249 p447-512
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M Folegatti, et al on behalf of the Oxford COVID Vaccine Trial Group